Evidence map›Paper›PMID 27337592›Full record

ArticleNature communications2016

MAIT cells are activated during human viral infections.

Bonnie van Wilgenburg, Iris Scherwitzl, Edward C Hutchinson, Tianqi Leng, Ayako Kurioka, Corinna Kulicke, Catherine de Lara, Suzanne Cole, Sirijitt Vasanawathana, Wannee Limpitikul and 17 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 323 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
323citing papers in PubMed, 1 pooled it
24.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

323 citing papers in PubMed, 1 synthesis or guideline pooled it, 512 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Gut archaea drive human MAIT cell responses.bioRxiv : the preprint server for biology · 2026
    Article
  6. Single-cell RNA profiling suggests goflikicept-mediated immune modulation in idiopathic recurrent pericarditis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Gastrointestinal MAIT cells in chronic HIV-1 infection.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Article
  20. Article

263 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 20 institutions in 7 countries.

Bonnie van WilgenburgPeter Medawar Building for Pathogen Research and Translational Gastroenterology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX1 3SY, UK.ORCID 0000-0002-0038-584X
Iris ScherwitzlDivision of Immunology and Inflammation, Department of Medicine, Faculty of Medicine, Imperial College, Hammersmith Campus, London W12 0NN, UK.
Edward C HutchinsonSir William Dunn School of Pathology, University of Oxford, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.ORCID 0000-0003-3673-9096
Tianqi LengPeter Medawar Building for Pathogen Research and Translational Gastroenterology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX1 3SY, UK.
Ayako KuriokaPeter Medawar Building for Pathogen Research and Translational Gastroenterology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX1 3SY, UK.
Corinna KulickePeter Medawar Building for Pathogen Research and Translational Gastroenterology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX1 3SY, UK.
Catherine de LaraPeter Medawar Building for Pathogen Research and Translational Gastroenterology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX1 3SY, UK.
Suzanne ColeMRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 9DU, UK.
Sirijitt VasanawathanaDepartment of Pediatric, Khon Kaen Hospital, Khon Kaen 40000, Thailand.
Wannee LimpitikulDepartment of Pediatric, Songkhla Hospital, Songkhla 90100, Thailand.
Prida MalasitBIOTEC, NSTDA, Phatumthani 12120, Thailand.
Duncan YoungNuffield Department of Anesthesia, The John Radcliffe Hospital, Oxford OX3 9DU, UK.
Laura DenneyMRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 9DU, UK.
STOP-HCV consortium
Michael D MooreSir William Dunn School of Pathology, University of Oxford, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.
Paolo FabrisInfectious Diseases and Tropical Medicine Unit, San Bortolo Hospital, Vicenza, VI 37, Italy.
Maria Teresa GiordaniInfectious Diseases and Tropical Medicine Unit, San Bortolo Hospital, Vicenza, VI 37, Italy.
Ye Htun OoCentre for Liver Research &NIHR Biomedical Research Unit in Liver Disease, University of Birmingham, Birmingham B15 2TT, UK.
Stephen M LaidlawNuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, Kennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7 LF, UK.
Lynn B DustinNuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, Kennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7 LF, UK.
Ling-Pei HoMRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 9DU, UK.
Fiona M ThompsonPeter Medawar Building for Pathogen Research and Translational Gastroenterology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX1 3SY, UK.
Narayan RamamurthyPeter Medawar Building for Pathogen Research and Translational Gastroenterology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX1 3SY, UK.
Juthathip MongkolsapayaDivision of Immunology and Inflammation, Department of Medicine, Faculty of Medicine, Imperial College, Hammersmith Campus, London W12 0NN, UK.
Christian B WillbergPeter Medawar Building for Pathogen Research and Translational Gastroenterology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX1 3SY, UK.ORCID 0000-0001-5299-9344
Gavin R ScreatonDivision of Immunology and Inflammation, Department of Medicine, Faculty of Medicine, Imperial College, Hammersmith Campus, London W12 0NN, UK.
Paul KlenermanPeter Medawar Building for Pathogen Research and Translational Gastroenterology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX1 3SY, UK.ORCID 0000-0003-4307-9161
University of Oxford · GBJohn Radcliffe Hospital · GBUniversity of Nottingham · GBHammersmith Hospital · GBNuffield Orthopaedic Centre · GBOspedale San Bortolo · ITThe Hepatitis C Trust · GBUniversity of Glasgow · GBCentre for Human Genetics · GBConatus Pharmaceuticals (United States) · USGilead Sciences (United Kingdom) · GBImperial College London · GBJanssen (Belgium) · BEKhon Kaen University · THLondon School of Hygiene & Tropical Medicine · GBMedivir (Sweden) · SEMerck & Co., Inc., Rahway, NJ, USA (United States) · USNational Science and Technology Development Agency · THNIHR Birmingham Liver Biomedical Research Unit · GBNottingham City Hospital · GB

Funding

Virology CoreU19AI082630 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG, GEORG Michael LAUER · 2009 to 2026
$48.1M
Medical Research Council G0400720Medical Research Council G0400802Medical Research Council G0600000Medical Research Council G0600371Medical Research Council G0801508Medical Research Council G1002552Medical Research Council G1100247Medical Research Council MC_PC_12020Medical Research Council MC_UU_12014/9Medical Research Council MR/K000241/1Medical Research Council MR/K010239/1Medical Research Council MR/K01532X/1Medical Research Council MR/N012658/1NIAID NIH HHS U19 AI082630Wellcome Trust 091663Wellcome Trust 109965/Z/15/Z
6 · The paper itself

Abstract

Mucosal-associated invariant T (MAIT) cells are abundant in humans and recognize bacterial ligands. Here, we demonstrate that MAIT cells are also activated during human viral infections in vivo. MAIT cells activation was observed during infection with dengue virus, hepatitis C virus and influenza virus. This activation-driving cytokine release and Granzyme B upregulation-is TCR-independent but dependent on IL-18 in synergy with IL-12, IL-15 and/or interferon-α/β. IL-18 levels and MAIT cell activation correlate with disease severity in acute dengue infection. Furthermore, HCV treatment with interferon-α leads to specific MAIT cell activation in vivo in parallel with an enhanced therapeutic response. Moreover, TCR-independent activation of MAIT cells leads to a reduction of HCV replication in vitro mediated by IFN-γ. Together these data demonstrate MAIT cells are activated following viral infections, and suggest a potential role in both host defence and immunopathology.

Indexed as

AdultCells, CulturedCoculture TechniquesCytokinesFemaleHumansLeukocytes, MononuclearLymphocyte ActivationMaleMucosal-Associated Invariant T CellsVirus DiseasesCytokines

Identifiers

PMID27337592
PMCPMC4931007
OpenAlexW2464020216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.